本文選題：基因轉(zhuǎn)導(dǎo) + P16衍生肽　； 參考：《吉林大學(xué)》2014年碩士論文

【摘要】：提高基因治療的效率需要合適的基因載體系統(tǒng)和逐漸發(fā)展的用于增強(qiáng)基因轉(zhuǎn)導(dǎo)化合物的使用。逆轉(zhuǎn)錄病毒載體使外源基因在宿主細(xì)胞內(nèi)實(shí)現(xiàn)穩(wěn)定、長期的表達(dá)而占有很大的優(yōu)勢。 病毒與靶細(xì)胞表面的負(fù)電荷產(chǎn)生的靜電斥力大大限制了基因轉(zhuǎn)導(dǎo)的效率。用于增強(qiáng)基因轉(zhuǎn)導(dǎo)的化合物從最初的陽離子化合物Poly-L-lysine等發(fā)展至今，商品化的DEAE dextran和polybrene仍被人們廣泛應(yīng)用于基因轉(zhuǎn)導(dǎo)的實(shí)驗(yàn)中。最近的研究表明，淀粉樣纖維多肽在促進(jìn)基因轉(zhuǎn)導(dǎo)過程中具有突出的優(yōu)勢，如SEVI和EF-C，已經(jīng)被人們證實(shí)可以提高逆轉(zhuǎn)錄病毒基因轉(zhuǎn)導(dǎo)的效率，而且顯著強(qiáng)于DEAE和polybrene。 最近我們發(fā)現(xiàn)合成的HIV-14E10表位多肽P13（Ac-671NWFDITNWLWY-IK683-NH2）及其衍生肽P16（Ac-671NWFDITNWLWYIK683KKK-NH2），P16在P13序列C末端增加三個(gè)賴氨酸，也能夠形成淀粉樣纖維結(jié)構(gòu)促進(jìn)HIV-1感染，并且效率強(qiáng)于SEVI。對P13和P16促感染機(jī)理的研究表明，芳香族氨基酸色氨酸和堿性氨基酸賴氨酸對P16的促感染活性很重要。由它們的作用方式來看，淀粉樣纖維和正電性是多肽多聚物行使功能的必要條件。 本文的研究主要是在有利于淀粉樣纖維結(jié)構(gòu)形成的前提下，對P16序列中的酸性氨基酸--天冬氨酸進(jìn)行突變或增加序列中堿性氨基酸的數(shù)目，以期獲得促感染活性更好的多肽。實(shí)驗(yàn)中合成的多肽有P16-D、P16-K、P16-N、P16-2W和P16-W3K。對合成的多肽進(jìn)行MS和HPLC的質(zhì)量檢測無誤后，按照P16發(fā)揮最佳感染增強(qiáng)效果的條件，即在無血清條件下感染4h后再補(bǔ)加血清或更換為完全培養(yǎng)基，我們對合成的P16衍生肽的促感染活性進(jìn)行了研究。綜合考慮促進(jìn)病毒感染的效率和細(xì)胞毒性兩個(gè)因素，選用P16-D（Ac-671NW FAITNWLWYIK683K-KK-NH2）為研究對象。 病毒感染實(shí)驗(yàn)結(jié)果表明P16-D與P16增強(qiáng)病毒感染的倍數(shù)分別是13.9和7.5，充分說明改造后的P16-D的促感染活性在P16基礎(chǔ)上提高將近100%，同時(shí)與最適作用濃度DEAE和polybrene相比，促感染過程中細(xì)胞存活率分別是90%與80%左右，P16-D對靶細(xì)胞的毒性更低。 TEM、Tht特異性結(jié)合實(shí)驗(yàn)及EGCG實(shí)驗(yàn)表明P16-D經(jīng)過低速攪拌形成典型的淀粉樣纖維結(jié)構(gòu)，能夠有效地捕獲靶細(xì)胞和病毒顆粒，同時(shí)也使病毒顆粒通過簡單地低速離心就可以達(dá)到濃縮的目的。P16-D淀粉樣纖維的促感染活性對HIV-1以外的包膜病毒—流感病毒及FIV載體系統(tǒng)也適用。 鑒于P16-D淀粉樣多肽也能有效地捕獲流感病毒顆粒；在P16-D存在時(shí)，流感病毒的血凝效價(jià)比不加多肽組提高4倍；流感病毒感染MDCK細(xì)胞后，檢測上清里的病毒量，加肽組明顯高于不加肽組，預(yù)示著P16-D淀粉樣多肽將在流感病毒免疫中發(fā)揮特殊的作用。 理想的病毒抗原經(jīng)免疫后應(yīng)該既能引起體液免疫，又能引起細(xì)胞免疫�？紤]到P16-D纖維能夠有效地結(jié)合流感病毒顆粒，在細(xì)胞水平上促進(jìn)流感病毒的感染，我們選擇降低劑量的流感病毒配合P16-D淀粉樣纖維一起使用后，經(jīng)鼻腔接種小鼠后，特異性IgG抗體水平低于正常劑量病毒組，但是分型抗體IgG1的水平比后者要高，IgG2a的水平則與之相當(dāng)，，表明降低劑量的減毒流感病毒配合P16-D淀粉樣多肽使用，也能夠刺激機(jī)體產(chǎn)生有效的免疫應(yīng)答。 綜上，P16-D優(yōu)越的促感染活性預(yù)示著它將在逆轉(zhuǎn)錄病毒感染和基因治療中具有廣闊的應(yīng)用前景，同時(shí)，它在減毒的流感免疫中的應(yīng)用不僅幫助人們優(yōu)化免疫方案，降低生產(chǎn)成本，而且推動(dòng)了對淀粉樣纖維多聚物的深入認(rèn)識(shí)。
[Abstract]:In order to improve the efficiency of gene therapy, a suitable gene carrier system and the growing use of gene transducing compounds are needed. Retroviral vectors make foreign genes stable and long-term expression in host cells.
The electrostatic repulsion produced by the negative charges on the surface of the virus and the target cell greatly restricts the efficiency of gene transduction. The commercialized DEAE dextran and Polybrene are still widely used in the experiment of gene transduction from the initial cationic compound Poly-L-lysine, which is used to enhance gene transduction. Recent studies have shown that Amyloid polypeptide has prominent advantages in promoting gene transduction, such as SEVI and EF-C, which have been proved to improve the efficiency of retroviral gene transduction, and are significantly stronger than DEAE and polybrene..
Recently, we found that the synthesized HIV-14E10 epitope polypeptide P13 (Ac-671NWFDITNWLWY-IK683-NH2) and its derivative peptide P16 (Ac-671NWFDITNWLWYIK683KKK-NH2), P16 added three lysine at the C terminal of the P13 sequence, and can also form amyloid fiber structure to promote HIV-1 infection, and the efficiency is stronger than the mechanism of P13 and P16 promoting infection. The aromatic amino acid tryptophan and alkaline amino acid lysine are important for the infection promoting activity of P16. By their way of action, the amyloid fiber and the positive power are the necessary conditions for the function of polypeptide polymers.
The main research of this paper is to mutate the acid amino acid, aspartic acid in the P16 sequence, or increase the number of basic amino acids in the sequence, in order to obtain the polypeptide with better activity for promoting infection. The peptides synthesized in the experiment are P16-D, P16-K, P16-N, P16-2W and P16-W3K. for the synthesis of polypeptides. After testing the quality of MS and HPLC, the peptide can play the best effect on the enhancement of infection according to P16, that is, after infection of 4H in serum-free conditions, and then supplemented by serum or replaced as a complete medium, we have studied the infection promoting activity of the synthesized P16 derived peptide. Two factors which consider the efficiency of the infection and the cytotoxicity are considered. P16-D (Ac-671NW FAITNWLWYIK683K-KK-NH2) is chosen as the research object.
The results of virus infection test showed that the multiplier of P16-D and P16 enhanced virus infection were 13.9 and 7.5 respectively. It fully indicated that the reformed P16-D increased the infection activity by nearly 100% on the basis of P16. Compared with the optimum concentration DEAE and Polybrene, the cell survival rate in the infection process was 90% and 80%, respectively, and the toxicity of P16-D to the target cells. Sex is lower.
TEM, Tht specific binding experiments and EGCG experiments show that P16-D can form typical amyloid fibrils through low speed agitation and can effectively capture target cells and virus particles. Meanwhile, the virus particles can reach the concentrated target.P16-D amyloid fibrous activity against the envelope disease other than HIV-1 through a simple low-speed centrifugation. The virus - influenza virus and the FIV carrier system are also applicable.
The P16-D amyloid peptide can also effectively capture influenza virus particles; when P16-D exists, the blood coagulation titer of influenza virus is 4 times higher than that of the non polypeptide group; after influenza virus infection MDCK cells, the amount of virus in the supernatant is detected. The peptide group is obviously higher than the non peptide group, which indicates that the P16-D amyloid polypeptide will be immune to influenza virus immunity. A special role.
The ideal virus antigen should be immune to both body fluid immunity and cell immunity. Considering that P16-D fiber can effectively combine influenza virus particles and promote the infection of influenza virus at the cell level, we choose the reduced dose of influenza virus to be used together with the P16-D starch like fiber and inoculate mice through the nasal cavity. After that, the level of specific IgG antibody was lower than that in the normal dose virus group, but the level of the type antibody IgG1 was higher than that of the latter, and the level of the IgG2a was equal to that of the latter, indicating that the reduced dose of the attenuated influenza virus and the use of the P16-D amyloid polypeptide could also stimulate the organism to produce an effective immune response.
In conclusion, the superior infection activity of P16-D indicates that it will have a broad application prospect in retroviral infection and gene therapy. At the same time, its application in attenuated influenza immunity not only helps people to optimize the immune scheme, reduces the cost of production, but also promotes a deep understanding of the polypolymer of starch like fiber.
【學(xué)位授予單位】：吉林大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2014
【分類號(hào)】：R392.11

【共引文獻(xiàn)】

相關(guān)期刊論文 前10條

1 葛鵬飛;羅毅男;付雙林;周立祥;陳大瑋;王海峰;;缺血再灌注對大鼠海馬CA1及DG神經(jīng)元內(nèi)19S蛋白酶體影響的激光掃描共聚焦顯微鏡研究[J];中華神經(jīng)醫(yī)學(xué)雜志;2006年12期

2 葛鵬飛;付雙林;羅毅男;李文臣;王光明;林佳;羅天飛;;缺血再灌注后蛋白集聚與皮層神經(jīng)元延遲性死亡的關(guān)系[J];中華神經(jīng)醫(yī)學(xué)雜志;2007年06期

3 ;Aggregation Patterns of Proteasome in Injured Neurons Induced by Transient Cerebral Ischemia[J];Chemical Research in Chinese Universities;2011年02期

4 劉佳佳;李文峗;張磊;梁承遠(yuǎn);姚其正;;C3取代靛紅衍生物的研究進(jìn)展[J];國外醫(yī)藥(抗生素分冊);2013年03期

5 尹建元;John A.Carver;David C.Thorn;劉繼華;;磷脂和硫酸肝素對α_(s1)-酪蛋白淀粉樣纖維沉淀形成的影響[J];高等學(xué)�；瘜W(xué)學(xué)報(bào);2013年08期

6 何寧;孫賀春;徐歡喜;董曉曼;邵張章;;可降解非病毒基因載體PEG-b-(PG-g-PEI)的合成與表征[J];南方醫(yī)科大學(xué)學(xué)報(bào);2013年11期

7 周鵬;吉邢虎;何治柯;;蛋白質(zhì)自組裝及分析應(yīng)用[J];分析科學(xué)學(xué)報(bào);2014年02期

8 李亞文;徐世元;張慶國;李樂;賴露穎;鄭艇;蘇嬌玲;楊耐梅;李元濤;;Grp78基因過表達(dá)慢病毒載體構(gòu)建和包裝及鑒定[J];重慶醫(yī)學(xué);2014年15期

9 蔡晶晶;宋小平;嚴(yán)繼貴;王雅潔;;慢病毒載體包裝與生產(chǎn)方法[J];長江大學(xué)學(xué)報(bào)(自科版);2014年09期

10 馬寧;董曉燕;姜艷芳;劉蒙蒙;劉子玲;;利用Gateway克隆技術(shù)構(gòu)建人Hiwi腺病毒載體[J];吉林大學(xué)學(xué)報(bào)(醫(yī)學(xué)版);2014年04期

相關(guān)博士學(xué)位論文 前10條

1 李慧玉;小肽阻滯劑和納米碳管對淀粉樣肽結(jié)構(gòu)和熱力學(xué)性質(zhì)影響的分子動(dòng)力學(xué)研究[D];復(fù)旦大學(xué);2011年

2 劉更;1.低濃度MNNG激活內(nèi)質(zhì)網(wǎng)應(yīng)激及其對EGFR通路的影響 2.內(nèi)質(zhì)網(wǎng)應(yīng)激參與低濃度DNA加成性損傷劑誘發(fā)的細(xì)胞應(yīng)答反應(yīng)[D];浙江大學(xué);2005年

3 魏海燕;酵母朊蛋白Sup35NM體外淀粉樣纖維形成與解聚的動(dòng)力學(xué)及其細(xì)胞毒性研究[D];山東大學(xué);2006年

4 夏鷹;雪旺氏細(xì)胞和神經(jīng)干細(xì)胞共移植治療帕金森病動(dòng)物模型的實(shí)驗(yàn)研究[D];復(fù)旦大學(xué);2006年

5 季永運(yùn);蛋白質(zhì)折疊及其誤折疊病問題的簡單模型研究[D];浙江大學(xué);2006年

6 周拯;大分子擁擠環(huán)境中朊蛋白錯(cuò)誤折疊機(jī)制研究[D];武漢大學(xué);2009年

7 張e

本文編號(hào)：1906959